UK takes steps to speed up patient access to new treatments in hospitals
This article was originally published in RAJ Devices
The UK’s health technology assessment body, the National Institute for Health and Clinical Excellence, together with the Department of Health, has proposed new measures to speed up patient access to new health technologies under the government-funded National Health Service1. This includes a consultation on proposed changes to the way that topics (covering pharmaceuticals, biopharmaceuticals, devices and diagnostics) are chosen and referred for NICE’s appraisals of new drugs and treatments2.
You may also be interested in...
A new EU pilot will help drug regulators and policymakers understand the factors influencing the uneven availability of centrally authorized medicines in the member states.
A damning UK report makes uncomfortable reading about how thousands of women suffered avoidable harm from the anti-epileptic drug sodium valproate and two other medical interventions and how safety concerns raised were dismissed, overlooked and ignored.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.